Latest Stanford University School of Medicine Stories

PHILADELPHIA, June 13, 2013 /PRNewswire-USNewswire/ -- Twenty-two of the nation's most enterprising researchers were named Pew Scholars in the Biomedical Sciences by The Pew Charitable Trusts today. The scholarships provide flexible funding to early-career scientists researching the basis of perplexing health problems such as diabetes, autism, Parkinson's disease, and cancer. The new scholars join a prestigious community of researchers who have gone on to become Nobel laureates,...

A Stanford, CA Board Certified physician specializing in Vascular & Interventional Radiology, Dr. William T. Kuo, is a Castle Connolly Top Doctor for 2013. STANFORD, Calif., May 2, 2013 /PRNewswire-USNewswire/ -- Castle Connolly Medical Ltd., America's trusted source for identifying Top Doctors, has selected Stanford's Vascular & Interventional Radiology specialist Dr. William T. Kuo for inclusion in its highly selective list of Regional Top Doctors this year. (Photo:...

SAN FRANCISCO, March 19, 2013 /PRNewswire/ -- Aviir Inc., a biotechnology company dedicated to enhanced detection and prevention of cardiovascular disease through innovative diagnostic tests, announced that Douglas Harrington, MD, Clinical Professor of Pathology at USC and Aviir Inc. CEO, addressed a select group of physicians and leading cardiologists on the Latest Advances in Cardiovascular Risk Assessment at a special invitation-only reception in San Francisco. The event took...

IRVINE, Calif., Feb. 19, 2013 /PRNewswire/ -- Aviir Inc., a biotechnology company dedicated to the prevention of cardiovascular disease through innovative laboratory tests, announced that it has signed an agreement with Partners & Partners (P&P) under which P&P will form the sole distributorship of Aviir testing products and technologies in 19 Middle Eastern and North African Countries. Through its affiliate, Qatar Heart Laboratory Holding, P&P intends to roll out,...

SAN DIEGO, Nov. 19, 2012 /PRNewswire/ -- Trovagene, Inc. (NASDAQ: TROV), a developer of transrenal molecular diagnostics, announced today that Dr. Paul Billings has joined the Company's Scientific Advisory Board. A board certified internist and clinical geneticist, Dr. Paul R. Billings currently serves as Chief Medical Officer at Life Technologies Corporation. Dr. Billings brings extensive expertise and clinical experience in the areas of genomics and molecular medicine. (Logo:...

IRVINE, Calif., Nov. 15, 2012 /PRNewswire/ -- Aviir Inc., a biotechnology company dedicated to the prevention of cardiovascular disease through innovative laboratory tests, announced today that a new peer reviewed study published in the November issue of Current Medical Research and Opinion demonstrated that its MIRISK VP (formerly TruRisk(TM)) Assessment is an improved method of determining who is likely to suffer from a heart attack within five years, allowing preventive measures...

Patients who have lost their sight due to some degenerative eye conditions may someday have their vision restored thanks to a new device developed by experts at the Stanford University School of Medicine. The unit, announced by Stanford on Sunday, is a type of retinal prosthesis that uses miniature cells similar to solar panels, which are surgically installed underneath the retina, along with a special pair of camera-equipped goggles and a pocket computer which processes the information...

Dramatic changes are needed in medical student education, including a substantial reduction in the number of traditional lectures, according to a perspective piece to be published May 3 in the New England Journal of Medicine by two Stanford University professors. Medical education has changed little in the past 100 years despite dramatic changes in the world of medicine, the explosion in biomedical information and the ever-growing complexity of the health-care system. The traditional...

Stanford University School of Medicine investigators have shown that iPS cells, viewed as a possible alternative to human embryonic stem cells, can mirror the defining defects of a genetic condition — in this instance, Marfan syndrome — as well as embryonic stem cells can. An immediate implication is that iPS cells could be used to examine the molecular aspects of Marfan on a personalized basis. Embryonic stem cells, on the other hand, can't do this because their genetic contents are...

Neuroscientists have homed in on potential differences in the brain cells of autistic people by studying brainlike spheres grown in an elaborate process from skin cells. The scientists from Stanford University School of Medicine studied cells from patients suffering from Timothy syndrome, a rare genetic condition that is associated with one of the most penetrant forms of autism. Most people with the Timothy syndrome mutation have, among other health issues, autism as a symptom. Autism...